Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway

por Pang, Shu-chao, Peng, Li, Zhang, Jun-ping, Wang, Yuan-yuan, Jia, Hui-yun, Bi, Li-yuan, Chen, Mei-ling
Publicado 2018

BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE(−/−) Mice

por Pang, Shu-chao, Wang, Shuo, Chen, Mei-ling, Zhang, Jun-ping, Wang, Yuan-yuan, Jia, Hui-yun, Bi, Li-yuan, Wang, Hui
Publicado 2019